Recombinant human soluble thrombomodulin vs heparin
Mortality from any cause (15‐day and 30‐day in‐hospital) · DIC
It is very uncertain whether recombinant human soluble thrombomodulin changes mortality from any cause (15‐day and 30‐day in‐hospital) compared with heparin (very low certainty).
1 finding from 1 review
- Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia 2015 · Cochrane Headline outcomes onlyRR 0.85 [0.54, 1.36]1 study · 227 participantsVery low